ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGR Assura Plc

40.88
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Assura Plc LSE:AGR London Ordinary Share GB00BVGBWW93 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 40.88 40.56 40.68 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Real Estate Agents & Mgrs 150.4M -119.2M -0.0402 -10.17 1.21B

Assura PLC Trading Update (1070E)

02/07/2019 7:00am

UK Regulatory


Assura (LSE:AGR)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Assura Charts.

TIDMAGR

RNS Number : 1070E

Assura PLC

02 July 2019

2 July 2019

Assura plc

Trading Update

For the first quarter to 30 June 2019

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of GBP17 million which was above book value.

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial GBP92 million.

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

"We remain confident in our outlook for the full year and in our longer-term prospects."

Developments and strategic acquisitions strengthen market-leading portfolio

-- One development completed (Darley Dale) at a cost of GBP2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of GBP58 million.

   --      Two acquisitions completed in the period at a cost of GBP5.5 million. 

-- 12 disposals completed for GBP17 million cash consideration at a small premium to book value.

GPI acquisition expands pipeline

   --      Current portfolio of 554 properties. 
   --      Immediate development pipeline of GBP77 million. 

-- Immediate acquisitions pipeline increased to GBP64 million, compared with GBP41 million at March 2019.

-- Total immediate pipeline value, including on site developments, of GBP199 million up from GBP142 million at the year end.

Active portfolio management delivering value

-- Six lease re-gears agreed on GBP0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

   --      Annualised rent roll at GBP102.1 million post disposals. 

Strong financial position

-- As at 30 June 2019 gross debt GBP730 million with undrawn facilities of GBP230 million plus cash balance of GBP47.5 million.

ENDS

For further information, please contact:

 
 
   Assura plc:                          Tel: 01925 420 660 
   Jayne Cottam, CFO 
   Orla Ball, Company Secretary 
   David Purcell, Head of Financial 
   Reporting 
 
   Finsbury:                            Tel: 0207 251 3801 
   Gordon Simpson 
   James Thompson 
 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at GBP1,979 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TSTLLFLRDEILIIA

(END) Dow Jones Newswires

July 02, 2019 02:00 ET (06:00 GMT)

1 Year Assura Chart

1 Year Assura Chart

1 Month Assura Chart

1 Month Assura Chart

Your Recent History

Delayed Upgrade Clock